Abstract
Healthcare has played a main role in the Semantic Web (SW) field given the knowledge representation possibilities that SW is capable of addressing. Nowadays there are a large number of ontologies which can be used for several domains of healthcare (genetics, proteins, cellular components, anatomy, and specific diseases among others). However, in some cases, the definition and population of these ontologies are not enough to be used in concrete domains. In this paper we provide the design of a set of ontologies for their direct use in diagnostic decision support systems. We have designed an ontology modular architecture where main (root) ontology is created to define the main relations which can be found in the aforementioned domain. A set of subsumed ontologies has also been designed following some principles of OBO-Foundry and using SNOMED-CT terminology as the main interoperability component. These ontologies have been also designed trying to create them as light as possible. The evaluation of the designed ontology is based on a set of quantitative aspects which aims to show the main principles which should be followed in the process of design ontologies for the domain of differential diagnosis.
Keywords: Knowledge representation, medical diagnosis, ontology, Semantic web, Healthcare, in diagnostic decision support systems, OBO-Foundry, SNOMED-CT, DDxOnt, Interoperability Database.
Current Bioinformatics
Title:Towards an Ontology to Support Semantics Enabled Diagnostic Decision Support Systems
Volume: 7 Issue: 3
Author(s): Alejandro Rodriguez-Gonzalez, Gandhi Hernandez-Chan, Ricardo Colomo-Palacios, Juan Miguel Gomez-Berbis, Angel Garcia-Crespo, Giner Alor-Hernandez and Rafael Valencia-Garcia
Affiliation:
Keywords: Knowledge representation, medical diagnosis, ontology, Semantic web, Healthcare, in diagnostic decision support systems, OBO-Foundry, SNOMED-CT, DDxOnt, Interoperability Database.
Abstract: Healthcare has played a main role in the Semantic Web (SW) field given the knowledge representation possibilities that SW is capable of addressing. Nowadays there are a large number of ontologies which can be used for several domains of healthcare (genetics, proteins, cellular components, anatomy, and specific diseases among others). However, in some cases, the definition and population of these ontologies are not enough to be used in concrete domains. In this paper we provide the design of a set of ontologies for their direct use in diagnostic decision support systems. We have designed an ontology modular architecture where main (root) ontology is created to define the main relations which can be found in the aforementioned domain. A set of subsumed ontologies has also been designed following some principles of OBO-Foundry and using SNOMED-CT terminology as the main interoperability component. These ontologies have been also designed trying to create them as light as possible. The evaluation of the designed ontology is based on a set of quantitative aspects which aims to show the main principles which should be followed in the process of design ontologies for the domain of differential diagnosis.
Export Options
About this article
Cite this article as:
Rodriguez-Gonzalez Alejandro, Hernandez-Chan Gandhi, Colomo-Palacios Ricardo, Miguel Gomez-Berbis Juan, Garcia-Crespo Angel, Alor-Hernandez Giner and Valencia-Garcia Rafael, Towards an Ontology to Support Semantics Enabled Diagnostic Decision Support Systems, Current Bioinformatics 2012; 7(3) . https://dx.doi.org/10.2174/157489312802460721
DOI https://dx.doi.org/10.2174/157489312802460721 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
The Genetic Landscapes of Inflammation-Driven Gastrointestinal Tract Cancers
Current Pharmaceutical Design Withdrawal Notice: Prognosis And Prediction Of Breast Cancer (Bc) Using Growing Mlt (Machine Learning Techniques)
Recent Advances in Computer Science and Communications Genetic Variation at the Human MGMT Locus and its Biological Consequences
Current Pharmacogenomics DNA Methylation Based Biomarkers in Non-Invasive Cancer Screening
Current Molecular Medicine The History and Rationale for Monoclonal Antibodies in the Treatment of Hematologic Malignancy
Current Pharmaceutical Biotechnology Emerging Therapies in Chronic Myeloid Leukemia
Current Cancer Drug Targets Resistance to Crizotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) with ALK Rearrangement: Mechanisms, Treatment Strategies and New Targeted Therapies
Current Clinical Pharmacology Synthesis of Pyrophosphate-Containing Compounds that Stimulate VγVδ2 T Cells: Application to Cancer Immunotherapy
Medicinal Chemistry Structure-Activity Relationship Study of a Series of N-Substituted Piperazinyl-Fluoroquinolones as Anti-Helicobacter pylori Agents
Medicinal Chemistry Optimizing Outcomes Following Allogeneic Hematopoietic Progenitor Cell Transplantation in AML: The Role of Hypomethylating Agents
Current Cancer Drug Targets Anti-IL-13 in Inflammatory Bowel Disease: From the Bench to the Bedside
Current Drug Targets Megaspinoxide A: New Norterpene Cyclic Peroxide from the Sponge Diacarnus megaspinorhabdosa
The Natural Products Journal Biomarkers of Protein Oxidation in Human Disease
Current Molecular Medicine Topical Imiquimod: Mechanism of Action and Clinical Applications
Mini-Reviews in Medicinal Chemistry Novel Synthetic Lethality Approaches for Drug Combinations and Early Drug Development
Current Cancer Drug Targets Telomeres and Thyroid Cancer
Current Genomics The Use of Anthracyclines for Therapy of CNS Tumors
Anti-Cancer Agents in Medicinal Chemistry Clustering Algorithms: On Learning, Validation, Performance, and Applications to Genomics
Current Genomics Trends in Utilization of the Pharmacological Potential of Chalcones
Current Clinical Pharmacology Lessons we Learned from High-Throughput and Top-Down Systems Biology Analyses about Glioma Stem Cells
Current Pharmaceutical Design